HHS challenges Vertex Pharmaceuticals' fertility services program, alleging violations of anti-kickback laws linked to its ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive at the J.P. Morgan Healthcare ...

During the last century, biologists have extensively studied Drosophila melanogaster, the common household fruit fly. It's ...

The Dutch fashion retailer’s Omoda Stylist platform leverages Google Cloud’s Vertex AI platform and Gemini models for a tailored shopping experience.

This collaboration is set to revolutionize the industrial mobile communications landscape by introducing intrinsically safe ...

Wall Street stocks were in the red early on Thursday as Q4 earnings season began to pick up steam. As of 1530 GMT, the Dow ...

Hitachi Vantara, the data storage, infrastructure, and hybrid cloud management subsidiary of Hitachi, Ltd. (TSE: 6501), today announced that Malayala Manorama, India's second-largest newspaper by ...

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though ...